Sign In

Suzana Kahn

Senior Scientist at Genentech

Professional Background

Suzana Kahn is a distinguished cell biologist and immunologist specializing in cancer research, immuno-oncology, and pharmacology. With over seven years of comprehensive experience across both academia and the pharmaceutical industry, she possesses a unique blend of expertise that is crucial for the advancement of cancer therapies. As a senior scientist at Genentech, she plays a pivotal role in innovating preclinical drug discovery and development. Her work primarily focuses on therapeutic target identification and validation, with a remarkable track record in biomarker discovery and oncology pharmacology.

Throughout her career, Suzana has displayed exceptional proficiency in myeloid and stem cell biology associated with human cancers. She is adept in utilizing mouse models for oncology drug development and conducts in-depth investigations into the complex mechanisms and signaling pathways that drive tumor initiation, progression, and heterogeneity. Additionally, her research explores crucial areas like the tumor microenvironment and drug resistance, making her contributions invaluable in the quest for effective cancer treatments. Her dedication to scientific inquiry is complemented by excellent interpersonal and communication skills, enhancing her ability to work effectively within a collaborative research setting.

Education and Achievements

Suzana Kahn's impressive educational background begins with her Bachelor of Science in Biomedical Sciences from Universidade Federal do Rio de Janeiro, where she graduated Magna Cum Laude. She further honed her expertise in oncology and cancer biology by earning a Ph.D. from the prestigious Université Paris-Sorbonne. Her academic journey was enriched by a profound focus on cancer research and immunology at Stanford University, where she conducted cutting-edge research as a Pew Postdoctoral Fellow in the Irving Weissman Lab.

At Stanford, she also completed the Stanford Ignite program, obtaining a certificate in Innovation and Entrepreneurship from the Stanford Graduate School of Business. This unique blend of scientific and entrepreneurial training empowers her to bridge the gap between scientific discovery and real-world application, fostering innovation within the biomedical field.

Career Progression

Suzana's professional journey is marked by significant roles in top-tier organizations. She has cultivated her skills at Bristol Myers Squibb, where she served as Senior Scientist, Group and Project Leader for Immuno-Oncology Target Discovery. Her tenure at Bristol Myers Squibb allowed her to lead projects that significantly advanced the company's pipeline in cancer therapies, showcasing her strategic project management abilities.

Prior to her roles at Bristol Myers Squibb, she held positions such as Research Investigator II and I, allowing her to build a solid foundation in oncology research. Suzana's earlier experiences include her role as a Scientist I at the National Institute for Traumatology and Orthopedics and as a Postdoctoral Scholar at UFRJ, where she contributed to pivotal research projects.

Notable Achievements

Suzana Kahn has a remarkable track record of scientific publications that attest to her contributions to the field of cancer research. Her work has not only advanced understanding in her areas of expertise but has also provided a pathway for new therapies targeting cancer. As a team leader, she has demonstrated exceptional skills in problem-solving, project management, and multitasking, making her a highly effective scientist capable of thriving in fast-paced environments.

Her strong commitment to research excellence and innovation extends beyond her individual contributions. Suzana actively engages with her colleagues and the wider scientific community, offering mentorship and promoting collaborative efforts that inspire new ideas and drive further advancements in cancer therapy.

In summary, Suzana Kahn is a dedicated and accomplished scientist whose work continues to impact the fields of cancer research and immunology significantly. With her robust educational background, extensive industry experience, and prolific contributions to scientific literature, she exemplifies the qualities of a leader in her field. Her blend of technical acumen and interpersonal skills positions her as an invaluable asset to any research team focused on combating cancer through innovative drug discovery and development.

Related Questions

How did Suzana Kahn's studies at Stanford University influence her career in cancer research?
What innovative techniques does Suzana Kahn utilize in preclinical drug discovery?
Can you share insights on Suzana Kahn's role in advancing immuno-oncology during her time at Bristol Myers Squibb?
What challenges and successes has Suzana Kahn encountered in her work on drug resistance in cancer therapies?
How does Suzana Kahn integrate her training in innovation and entrepreneurship into her scientific research projects?
Suzana Kahn
Add to my network

Location

Palo Alto, California, United States